Effects of Digoxin on Angela’s Heart in Congestive Heart Failure

QUESTION

Angela is further evaluated for her chest pain and the cardiac studies show she is beginning to have congestive heart failure. The doctor writes and order for Digoxin. The nurse prepares the medication Digoxin according to the order. Select the effects of this Cardiac Glycoside you will expect on Angela’s heart (select all that apply) Angela is further evaluated for her chest pain and the cardiac studies show she is beginning to have congestive heart failure. The doctor writes and order for Digoxin. The nurse prepares the medication Digoxin according to the order. Select the effects of this Cardiac Glycoside you will expect on Angela’s heart (select all that apply) Increased spanatrophic action (maintains contractility, and stops cardiac output) positive inotropic action (increases contractility, stroke volume and, thus, cardiac output) Falsely elevated salicylate levels negative chronotropic action (decreases heart rate) negative dromotropic action (decrease conduction of cardiac cells)

ANSWER

Effects of Digoxin on Angela’s Heart in Congestive Heart Failure

Introduction

Angela is being evaluated for chest pain, and her cardiac studies have revealed the early signs of congestive heart failure. As part of her treatment plan, the doctor has prescribed Digoxin, a cardiac glycoside. Digoxin is a medication commonly used to manage heart conditions, including congestive heart failure. In this essay, we will discuss the expected effects of Digoxin on Angela’s heart, focusing on its actions as a cardiac glycoside.

Effects of Digoxin

Positive Inotropic Action

One of the primary effects of Digoxin on Angela’s heart is its positive inotropic action. This means that Digoxin enhances the contractility of the heart muscle. It does so by inhibiting the sodium-potassium pump, leading to an increase in intracellular calcium levels. This heightened contractility results in stronger and more efficient cardiac contractions, which, in turn, increase stroke volume and cardiac output. This effect is particularly beneficial in congestive heart failure, where the heart’s pumping ability may be compromised.

Negative Chronotropic Action

Digoxin also exerts a negative chronotropic action on Angela’s heart. This means that it decreases the heart rate. By slowing down the heart rate, Digoxin allows for more extended diastolic filling, which improves the heart’s efficiency and ensures that it can effectively eject blood during systole. This effect helps in controlling heart rate and can be valuable in cases of atrial fibrillation or other arrhythmias.

Negative Dromotropic Action

Another action of Digoxin is its negative dromotropic effect. This effect involves slowing the conduction of electrical impulses through the cardiac cells, primarily through the atrioventricular (AV) node. By doing so, Digoxin can help regulate the rhythm of the heart and prevent rapid conduction of impulses that may lead to arrhythmias.

Conclusion

In the management of Angela’s early-stage congestive heart failure, Digoxin plays a crucial role by exerting specific effects on her heart. These effects include positive inotropic action, which enhances the heart’s contractility and increases cardiac output, negative chronotropic action, which decreases heart rate to improve diastolic filling, and negative dromotropic action, which helps regulate cardiac rhythm.

It’s important to note that Digoxin is a potent medication, and its dosing must be carefully monitored to achieve the desired therapeutic effects while avoiding toxicity. Healthcare providers, including nurses, play a pivotal role in assessing and managing patients receiving Digoxin to ensure their safety and well-being. Angela’s response to Digoxin therapy will be closely monitored to optimize her cardiac function and overall health in the management of congestive heart failure.